Cargando…

Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA

The relationship of circulating testosterone levels with health outcomes in people with chronic obstructive pulmonary disease (COPD) is unknown. AIM: To determine whether serum testosterone levels predict hospitalised acute exacerbations of COPD (H-AECOPD), cardiovascular disease outcome, and mortal...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavey, Holly, Polkey, Michael I, Bolton, Charlotte E, Cheriyan, Joseph, McEniery, Carmel M, Wilkinson, Ian, Mohan, Divya, Casaburi, Richard, Miller, Bruce E, Tal-Singer, Ruth, Fisk, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277522/
https://www.ncbi.nlm.nih.gov/pubmed/37316306
http://dx.doi.org/10.1136/bmjresp-2022-001601
_version_ 1785060300750323712
author Pavey, Holly
Polkey, Michael I
Bolton, Charlotte E
Cheriyan, Joseph
McEniery, Carmel M
Wilkinson, Ian
Mohan, Divya
Casaburi, Richard
Miller, Bruce E
Tal-Singer, Ruth
Fisk, Marie
author_facet Pavey, Holly
Polkey, Michael I
Bolton, Charlotte E
Cheriyan, Joseph
McEniery, Carmel M
Wilkinson, Ian
Mohan, Divya
Casaburi, Richard
Miller, Bruce E
Tal-Singer, Ruth
Fisk, Marie
author_sort Pavey, Holly
collection PubMed
description The relationship of circulating testosterone levels with health outcomes in people with chronic obstructive pulmonary disease (COPD) is unknown. AIM: To determine whether serum testosterone levels predict hospitalised acute exacerbations of COPD (H-AECOPD), cardiovascular disease outcome, and mortality in people with COPD. METHODS: Separate analyses were carried out on two observational, multicentre COPD cohorts, Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) and Evaluation of the Role of Inflammation in Chronic Airways Disease (ERICA), both of which had serum testosterone measured using a validated liquid chromatography assay at the same laboratory. Data from 1296 male participants in ECLIPSE and 386 male, 239 female participants in ERICA were analysed. All analyses were sex-specific. Multivariate logistic regression was used to determine associations with H-AECOPD during follow-up (3 years ECLIPSE, 4.5 years ERICA), a composite endpoint of cardiovascular hospitalisation and cardiovascular death, and all-cause mortality. RESULTS: Mean (SD) testosterone levels were consistent across cohorts; 459 (197) and 455 (200) ng/dL for males in ECLIPSE and ERICA, respectively, and in ERICA females: 28 (56) ng/dL. Testosterone was not associated with H-AECOPD (ECLIPSE: OR: 0.76, p=0.329, ERICA males: OR (95% CI): 1.06 (0.73 to 1.56), p=0.779, ERICA females: OR: 0.77 (0.52 to 1.12), p=0.178) or cardiovascular hospitalisation and death. Testosterone was associated with all-cause mortality in Global Initiative for Obstructive Lung Disease (GOLD) stage 2 male patients only, in ECLIPSE (OR: 0.25, p=0.007) and ERICA (OR: (95% CI): 0.56 (0.32 to 0.95), p=0.030). CONCLUSIONS: Testosterone levels do not relate to H-AECOPD or cardiovascular outcome in COPD, but are associated with all-cause mortality in GOLD stage 2 COPD male patients, although the clinical significance of this finding is uncertain.
format Online
Article
Text
id pubmed-10277522
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-102775222023-06-20 Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA Pavey, Holly Polkey, Michael I Bolton, Charlotte E Cheriyan, Joseph McEniery, Carmel M Wilkinson, Ian Mohan, Divya Casaburi, Richard Miller, Bruce E Tal-Singer, Ruth Fisk, Marie BMJ Open Respir Res Chronic Obstructive Pulmonary Disease The relationship of circulating testosterone levels with health outcomes in people with chronic obstructive pulmonary disease (COPD) is unknown. AIM: To determine whether serum testosterone levels predict hospitalised acute exacerbations of COPD (H-AECOPD), cardiovascular disease outcome, and mortality in people with COPD. METHODS: Separate analyses were carried out on two observational, multicentre COPD cohorts, Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) and Evaluation of the Role of Inflammation in Chronic Airways Disease (ERICA), both of which had serum testosterone measured using a validated liquid chromatography assay at the same laboratory. Data from 1296 male participants in ECLIPSE and 386 male, 239 female participants in ERICA were analysed. All analyses were sex-specific. Multivariate logistic regression was used to determine associations with H-AECOPD during follow-up (3 years ECLIPSE, 4.5 years ERICA), a composite endpoint of cardiovascular hospitalisation and cardiovascular death, and all-cause mortality. RESULTS: Mean (SD) testosterone levels were consistent across cohorts; 459 (197) and 455 (200) ng/dL for males in ECLIPSE and ERICA, respectively, and in ERICA females: 28 (56) ng/dL. Testosterone was not associated with H-AECOPD (ECLIPSE: OR: 0.76, p=0.329, ERICA males: OR (95% CI): 1.06 (0.73 to 1.56), p=0.779, ERICA females: OR: 0.77 (0.52 to 1.12), p=0.178) or cardiovascular hospitalisation and death. Testosterone was associated with all-cause mortality in Global Initiative for Obstructive Lung Disease (GOLD) stage 2 male patients only, in ECLIPSE (OR: 0.25, p=0.007) and ERICA (OR: (95% CI): 0.56 (0.32 to 0.95), p=0.030). CONCLUSIONS: Testosterone levels do not relate to H-AECOPD or cardiovascular outcome in COPD, but are associated with all-cause mortality in GOLD stage 2 COPD male patients, although the clinical significance of this finding is uncertain. BMJ Publishing Group 2023-06-14 /pmc/articles/PMC10277522/ /pubmed/37316306 http://dx.doi.org/10.1136/bmjresp-2022-001601 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Chronic Obstructive Pulmonary Disease
Pavey, Holly
Polkey, Michael I
Bolton, Charlotte E
Cheriyan, Joseph
McEniery, Carmel M
Wilkinson, Ian
Mohan, Divya
Casaburi, Richard
Miller, Bruce E
Tal-Singer, Ruth
Fisk, Marie
Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
title Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
title_full Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
title_fullStr Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
title_full_unstemmed Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
title_short Circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from ECLIPSE and ERICA
title_sort circulating testosterone levels and health outcomes in chronic obstructive pulmonary disease: results from eclipse and erica
topic Chronic Obstructive Pulmonary Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277522/
https://www.ncbi.nlm.nih.gov/pubmed/37316306
http://dx.doi.org/10.1136/bmjresp-2022-001601
work_keys_str_mv AT paveyholly circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica
AT polkeymichaeli circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica
AT boltoncharlottee circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica
AT cheriyanjoseph circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica
AT mcenierycarmelm circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica
AT wilkinsonian circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica
AT mohandivya circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica
AT casaburirichard circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica
AT millerbrucee circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica
AT talsingerruth circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica
AT fiskmarie circulatingtestosteronelevelsandhealthoutcomesinchronicobstructivepulmonarydiseaseresultsfromeclipseanderica